159 related articles for article (PubMed ID: 22519450)
1. Genetic variability of matrix metalloproteinase genes in cardiovascular disease.
Papageorgiou N; Tousoulis D; Hatzis G; Briasoulis A; Androulakis E; Giolis A; Siasos G; Latsios G; Vogiatzi G; Tentolouris C; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1206-13. PubMed ID: 22519450
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases in atherothrombosis.
Bäck M; Ketelhuth DF; Agewall S
Prog Cardiovasc Dis; 2010; 52(5):410-28. PubMed ID: 20226959
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.
Siasos G; Tousoulis D; Kioufis S; Oikonomou E; Siasou Z; Limperi M; Papavassiliou AG; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1132-48. PubMed ID: 22519444
[TBL] [Abstract][Full Text] [Related]
4. Myocardial structure and matrix metalloproteinases.
Aggeli C; Pietri P; Felekos I; Rautopoulos L; Toutouzas K; Tsiamis E; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1113-31. PubMed ID: 22519443
[TBL] [Abstract][Full Text] [Related]
5. Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome.
Ye S
Cardiovasc Res; 2006 Feb; 69(3):636-45. PubMed ID: 16122719
[TBL] [Abstract][Full Text] [Related]
6. Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.
Briasoulis A; Tousoulis D; Papageorgiou N; Kampoli AM; Androulakis E; Antoniades C; Tsiamis E; Latsios G; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1214-21. PubMed ID: 22519451
[TBL] [Abstract][Full Text] [Related]
7. Contributory role of matrix metalloproteinases in cardiovascular remodeling.
Gunasinghe SK; Ikonomidis J; Spinale FG
Curr Drug Targets Cardiovasc Haematol Disord; 2001 Dec; 1(2):75-91. PubMed ID: 12769658
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases.
Ye S
Matrix Biol; 2000 Dec; 19(7):623-9. PubMed ID: 11102751
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?
Creemers EE; Cleutjens JP; Smits JF; Daemen MJ
Circ Res; 2001 Aug; 89(3):201-10. PubMed ID: 11485970
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase: investigation from gene to protein as effective factor in myocardial infarction.
Ghaderian SM; Najar RA; Tabatabaei Panah AS; Rezaie G; Rezaei Farimani A; Beigi Harchegani A; Azargashb E
J Thromb Thrombolysis; 2010 Nov; 30(4):404-11. PubMed ID: 20221893
[TBL] [Abstract][Full Text] [Related]
11. Granulocytes in coronary thrombus evolution after myocardial infarction--time-dependent changes in expression of matrix metalloproteinases.
Li X; de Boer OJ; Ploegmaker H; Teeling P; Daemen MJ; de Winter RJ; van der Wal AC
Cardiovasc Pathol; 2016; 25(1):40-6. PubMed ID: 26490693
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases.
Zitka O; Kukacka J; Krizkova S; Huska D; Adam V; Masarik M; Prusa R; Kizek R
Curr Med Chem; 2010; 17(31):3751-68. PubMed ID: 20846107
[TBL] [Abstract][Full Text] [Related]
13. The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis.
Abilleira S; Bevan S; Markus HS
J Med Genet; 2006 Dec; 43(12):897-901. PubMed ID: 16905683
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.
Saracini C; Bolli P; Sticchi E; Pratesi G; Pulli R; Sofi F; Pratesi C; Gensini GF; Abbate R; Giusti B
J Vasc Surg; 2012 Jan; 55(1):171-179.e2. PubMed ID: 22094117
[TBL] [Abstract][Full Text] [Related]
15. The role of matrix metalloproteinases in diabetes mellitus.
Tsioufis C; Bafakis I; Kasiakogias A; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1159-65. PubMed ID: 22519446
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases and coronary artery diseases.
Ikeda U; Shimada K
Clin Cardiol; 2003 Feb; 26(2):55-9. PubMed ID: 12625594
[TBL] [Abstract][Full Text] [Related]
17. Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease.
Horne BD; Camp NJ; Carlquist JF; Muhlestein JB; Kolek MJ; Nicholas ZP; Anderson JL
Am Heart J; 2007 Oct; 154(4):751-8. PubMed ID: 17893005
[TBL] [Abstract][Full Text] [Related]
18. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture.
Newby AC
Physiol Rev; 2005 Jan; 85(1):1-31. PubMed ID: 15618476
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of matrix metalloproteinases in myocardial infarction: a meta-analysis.
Wang J; Xu D; Wu X; Zhou C; Wang H; Guo Y; Cao K
Heart; 2011 Oct; 97(19):1542-6. PubMed ID: 21900582
[TBL] [Abstract][Full Text] [Related]
20. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
Janssens S; Lijnen HR
Cardiovasc Res; 2006 Feb; 69(3):585-94. PubMed ID: 16426591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
